|4Sep 12, 4:58 PM ET

Hsu Jason 4

4 · Immix Biopharma, Inc. · Filed Sep 12, 2023

Insider Transaction Report

Form 4
Period: 2023-09-08
Hsu Jason
Director
Transactions
  • Purchase

    Common Stock

    2023-09-08$2.53/sh+10,000$25,317685,000 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    3,915,913
  • Common Stock

    (indirect: See Footnote)
    50,000
Footnotes (3)
  • [F1]This figure is the weighted average sales price of multiple trades ranging from $2.51 to $2.559 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.
  • [F2]Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
  • [F3]Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.

Documents

1 file
  • 4
    ownership.xmlPrimary